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omputed Tomography
oronary Angiography
or Screening
symptomatic Subjects
Bridge Too Far?*
im J. de Feyter, MD, FACC,†‡
arl J. Schultz, MD†
otterdam, the Netherlands
ultislice computed tomography (MSCT) coronary an-
iography (CA) has emerged as a powerful noninvasive
iagnostic modality to visualize the coronary arteries and the
anifestations of coronary atherosclerosis (1). Many reports
ave demonstrated that 64-slice computed tomography
CT) CA is a viable diagnostic modality to detect or rule out
he presence of significant coronary stenoses, but the precise
ole of MSCT-CA in the diagnostic work-up of patients
ith suspected CAD in relation to existing noninvasive
unctional tests (electrocardiogram-stress test, stress–single-
hoton emission CT, or dobutamine echocardiography) is
ot yet established, and the technique falls short to replace
nvasive coronary angiography.
See page 357
Computed tomography coronary imaging assesses, in
ddition to coronary integrity, comprehensive anatomical
nformation about location, extent, severity, and tissue
omposition of coronary atherosclerosis. An intriguing pos-
ibility of coronary CT is that the technique can assess the
resence of occult atherosclerosis and might develop as a
seful tool to screen for early detection of atherosclerosis in
symptomatic subjects. Because CT coronary imaging com-
rehensively evaluates the composition (calcific and noncal-
ific) of coronary plaques, it might provide prognostic
vidence independent of and incremental to simple CT
alcium scoring.
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.v
From the Departments of †Radiology and ‡Cardiology, Thoraxcentre, Erasmus
edical Center, Rotterdam, the Netherlands.So far, MSCT has not been explored extensively in
symptomatic subjects, and only a few reports have been
ublished indicating the feasibility of the technique (2,3).
Because approximately 50% of all acute coronary syn-
romes occur in previously asymptomatic subjects, there
bviously is a need to identify these subjects before coronary
therosclerosis becomes clinically manifest and irreversible
amage occurs by progression to myocardial infarction or
ardiac death (4).
It is customary to initially estimate a person’s risk of
ardiovascular death or myocardial infarction with tradi-
ional risk factors including age and gender to derive a risk
core—for instance, the Framingham Risk or European
isk Score (Systemic Coronary Risk Evaluation). However,
symptomatic subjects generally are at low risk score or, in
ase of the presence of more than 1 risk factor, might be at
ntermediate risk. In low-risk populations the prognostic
ccuracy of screening is far from perfect, and the incorpo-
ation of CT atherosclerotic imaging data into a coronary
rtery disease (CAD) risk score might improve existing
lgorithms for risk stratification.
In this issue of the Journal, Choi et al. (5) evaluated the
otential of MSCT coronary imaging in asymptomatic
ubjects. They investigated 2 important topics. First, they
ssessed the presence of occult coronary atherosclerosis, and
econd, they subsequently established the value of CT to
redict adverse coronary events. A total of 1,000 middle-
ged (50  9 years; range 35 to 75 years) Korean men (n 
26) and women (n  374) were evaluated who underwent
eneral routine health evaluation. These subjects were
elf-referrals, but much to the credit of the investigators, all
mportant risk parameters were objectively measured. More
han one-half of them were considered at low risk (0 to 1
isk factor), 30% were considered at moderate risk (more
han 2 risk factors but 10-year risk between 10% and 20%),
nd 10% at high risk (10-year risk 20%). These subjects
ere followed for a period of 17  2 months. The study of
hoi et al. (5) raises several questions.
First, is there need for a new noninvasive atherosclerosis
maging technique? Noninvasive atherosclerosis imaging tech-
iques, including ultrasound assessment of intima-media
hickness of the carotid artery, cardiovascular magnetic reso-
ance imaging for atherosclerosis, brachial artery endothelial
eactivity assessment, measurement of the ankle-brachial in-
ex, or coronary calcium scanning, might further enhance the
etection and management of patients at risk for coronary
eart disease, but they are not perfect. It is recognized that a
detection gap” exists that is defined as the difference between
oronary heart disease cases or events currently detected and
he total burden of disease or events among the population. (6)
his leaves room for the introduction of a new noninvasive
therosclerosis imaging technique.
Second, what is the prevalence of significant CAD in
symptomatic subjects using MSCT-CA? Currently only
ery few data are available about the diagnostic yield of
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July 29, 2008:366–8 Editorial CommentSCT-CA in asymptomatic high-risk subjects. Romeo
t al. (3), with MSCT in 168 asymptomatic high-risk
ubjects (age 60  7 years), found that the prevalence of
ignificant CAD (50% diameter stenosis) was 27% (1-
essel disease: 16%; 2-vessel disease: 7%; 3-vessel disease:
%; left main disease: 2.5%). The majority of these subjects
ere diabetic (100 of 168: 60%), of which 36% had evidence
f significant CAD. Bachar et al. (2) investigated 244
symptomatic high-risk subjects (age 54  8 years). They
dentified significant obstructive disease in 4.9%, mild-to-
oderate disease (50% diameter stenosis) in 51%, and no
therosclerosis in 44.3% of these subjects. The study of
hoi et al. (5) revealed similar findings. They identified an
therosclerotic plaque in 22% of the study population, of
hich 5% had evidence of a significant stenosis (diameter
tenosis 50%) and 2% had evidence of a severe stenosis
75% diameter stenosis). The majority had single-vessel
isease, and in 77% a stenosis was located on the left main
r proximal/mid left anterior descending artery.
These data show that MSCT coronary imaging not only
an document the presence of coronary atherosclerosis but
lso is able to identify subjects with significant 3-vessel, left
ain, or proximal left anterior descending artery disease.
hese subjects might benefit from coronary revasculariza-
ion, although studies are lacking to demonstrate that
evascularization might improve prognosis in asymptomatic
ubjects.
Third, what is the additional diagnostic value of MSCT
oronary imaging compared with CT coronary calcium
creening? Obviously coronary calcium scoring alone cannot
etect noncalcific or mixed plaques. The prevalence of
oncalcified plaques as the only manifestation of CAD is
ather low. A significant noncalcified obstruction was
resent in 7% (9 of 125) of the patients evaluated for acute
hest pain, between 6.2% to 6.5% in symptomatic subjects,
nd 4% in asymptomatic subjects (5,7–9) Intuitively com-
rehensive coronary imaging to assess the total coronary
laque burden with MSCT might be superior to simple
alcium screening, but so far no studies are available
howing that MSCT coronary imaging in either symptom-
tic or asymptomatic subjects will result in better risk
tratification and improvement of outcome compared with
alcium screening alone.
Fourth, what is the value of MSCT coronary imaging to
redict adverse coronary events? Because MSCT coronary
maging was introduced just recently, it is too early to expect
arge long-term follow-up studies to be available. Two
ecent published reports have demonstrated the predictive
alue of CT coronary imaging in symptomatic patients
10,11). Both studies clearly showed that the extent and
everity of coronary atherosclerosis present on MSCT were
ssociated with a worse prognosis compared with absence of
oronary atherosclerosis. In particular the presence of
-vessel disease and left main disease were associated with
orse prognosis. CThe strength of MSCT coronary imaging is the fact that
his noninvasive technique can identify significant CAD of
he left main or 3-vessel disease known to carry worse
rognosis, which can be improved by revascularization. This
ight (so far unproven) open new avenues to treat these
atients, including intense lifestyle modifications or risk
actor possibly or even revascularization. Although this
ight be effective for symptomatic patients, or asymptom-
tic subjects at high risk, this does not necessarily apply to
ow-risk asymptomatic individuals.
Future well-designed studies need to be conducted to
rovide substantial evidence that intervention in low-risk
symptomatic individuals is beneficial. The report of Choi
t al. (5) underscores that the design of prognostic study in
symptomatic subjects might be flawed. They assessed the
rognostic value in their population of 1,000 asymptomatic
ubjects during a follow-up period of 17  2 months.
ifteen cardiac events occurred in subjects with evidence of
AD, and none occurred in those without CAD. The
vents consisted of 1 unstable angina episode requiring
ospital stay and 14 revascularization procedures. It is of
ote that no hard events (death, nonfatal myocardial infarc-
ion) occurred, but more importantly, the revascularization
rocedures were triggered by the fact that both patients and
hysician were unblinded to the CT outcome data. Other
utcome studies should follow, with physicians and patients
linded to CT outcome, to provide reliable data about the
redictive value of CT coronary imaging with respect to hard
utcomes: cardiac death, or nonfatal myocardial infarction.
Fifth, is CT coronary imaging harmful? Computed to-
ography coronary imaging is associated with radiation
xposure and subsequent likelihood of radiation-induced
ncidence of cancer and cancer mortality (12). Newer CT
echnology and adapted CT protocols can significantly
educe the radiation exposure, but before embracing CT
oronary imaging as a routine screening procedure it needs
o be shown that the potential benefits of screening out-
eigh the potential harmful effects of MSCT-CA.
Another matter of concern is the high likelihood of false
ositive (i.e., false positive regarding prognostic value)
utcomes, turning asymptomatic healthy subjects into “pa-
ients” with occult coronary atherosclerosis, which might
rigger anxiety, further diagnostic procedures, and possibly
nnecessary treatment. Conversely, a negative outcome
tems To Be Addressed inuture Studies of CT Coronary Imaging
Table 1 Items To Be Addressed inFuture Studies of CT Coronary Imaging
Random sample of asymptomatic subjects (nonself-referrals)
Assess total MSCT plaque burden in low-, intermediate-, and high-risk subjects,
with doctors and subjects blinded to MSCT result (natural history)
Large sample size, long-term follow-up (5 to 10 yrs)
Randomized in case of intervention
Calcium screening versus total coronary plaque burden screening
Cost analysis (downstream diagnostic tests)
Hard end point: cardiac death or nonfatal myocardial infarctionT  computed tomography; MSCT  multi-slice computed tomography.
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Editorial Comment July 29, 2008:366–8ight lead to a false sense of security of health and neglect
f potentially favorable institution of risk factor modifica-
ion, and the risk (albeit low) of an acute coronary event
annot be excluded.
In conclusion, despite study design shortcomings, the
uthors are to be commended for their efforts to provide
nitial data concerning the role of CT imaging in asymp-
omatic subjects. They provided new insights into the
revalence, extent, and severity of coronary atherosclerosis
efore it has become clinically manifest. However, the study
lso demonstrated that in clinical reality it is difficult to
esign a study that provides convincing evidence that CT
oronary imaging has independent predictive value in addi-
ion to common risk factors. In our opinion studies con-
erning the predictive value of CT coronary imaging should
ontain the elements shown in Table 1. The report by Choi
t al. (5) will hopefully be the first of a large number of
tudies regarding the establishment of the use of CT
oronary imaging in asymptomatic individuals. We agree
ith Choi et al. (5) that we are far away from recommend-
ng CT screening in asymptomatic individuals and abide by
he recommendation statement of the U.S. Preventive
ervices Task Force against routine screening with resting
lectrocardiography, exercise treadmill test, and electron
eam CT in adults at low risk, which should also apply to
SCT coronary imaging screening (13).
eprint requests and correspondence: Dr. Pim J. de Feyter,
rasmus Medical Center, Departments of Cardiology and Radi-
logy, Postbus 2040, 3000 CA Rotterdam, the Netherlands.
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